HIGHLIGHTS
- who: Report and collaborators from the First Department of Propaedeutic Internal Medicine, Laiko General Hospital, National and Kapodistrian University have published the Article: Review began 07/12/2022 Review ended 07/19/2022 Published 07/25/2022 © Copyright, in the Journal: (JOURNAL) of July/25,/2022
- what: GSD-Ib is a rare, potentially life-threatening disease of carbohydrate metabolism, for which neutropenia/neutrophil dysfunction and IBD have, up to recently, been causing reduced quality of life of affected persons.
- future: This issue needs further investigation in future studies since empagliflozin is not officially . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.